<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001254</url>
  </required_header>
  <id_info>
    <org_study_id>900137</org_study_id>
    <secondary_id>90-DK-0137</secondary_id>
    <nct_id>NCT00001254</nct_id>
  </id_info>
  <brief_title>Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome</brief_title>
  <official_title>Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This protocol concerns the approach to the localization, diagnosis of MEN1 and management of
      the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the
      diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the
      subsequent management of the tumor and tissue samples for research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This protocol concerns the approach to the localization and management of the tumor in
      patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used
      to localize the tumor and the subsequent management of the tumor.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 1991</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine an approach to the localization and management of tumor in patients with ZES.</measure>
    <time_frame>Yearly</time_frame>
    <description>localization of tumor</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">273</enrollment>
  <condition>Zollinger Ellison Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Patients will Zollinger-Ellison Syndrome</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patient population enrolled in protocol 89-DK-0015
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

        New patients will be evaluated initially as described in the protocol entitled, &quot;Diagnostic
        evaluation of patients with suspected abnormalities of gastric secretion&quot; (89-DK-0005).

        Only those patients that are being treated under the protocol entitled, &quot;Medical Therapy of
        Zollinger-Ellison Syndrome&quot; (protocol # 89-DK-0015) will be entered into this tumor
        localization and management protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert T Jensen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_1990-DK-0137.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Wolfe MM, Jensen RT. Zollinger-Ellison syndrome. Current concepts in diagnosis and management. N Engl J Med. 1987 Nov 5;317(19):1200-9. Review.</citation>
    <PMID>3309661</PMID>
  </reference>
  <reference>
    <citation>Andersen DK. Current diagnosis and management of Zollinger-Ellison syndrome. Ann Surg. 1989 Dec;210(6):685-703. Review.</citation>
    <PMID>2686566</PMID>
  </reference>
  <reference>
    <citation>Creutzfeldt W, Arnold R, Creutzfeldt C, Track NS. Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol. 1975 Jan;6(1):47-76.</citation>
    <PMID>45919</PMID>
  </reference>
  <verification_date>February 4, 2020</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Zollinger-Ellison Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zollinger-Ellison Syndrome</mesh_term>
    <mesh_term>Gastrinoma</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

